This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated MST1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MST1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~80.3 kDa | |
| Observed band | ~80 kDa | |
| Gel | 8–10% | |
| Positive control | Adipose tissue+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
| PTM | Glycosylated + Cleaved | |
| Caveat | Alpha/beta chain cleavage | |
| Regulation | Coagulation | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for MST1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Hela , Lane 2: human MCF-7 , Lane 3: human HepG2 , Lane 4: human SK-OV-3 , Lane 5: human A549 , Lane 6: rat kidney , Lane 7: mouse kidney . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-MST1 antigen affinity purified polyclonal antibody (Catalog # A01069-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for MST1 at approximately 80KD. The expected band size for MST1 is at 80KD |
| Gel % | 8–10% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:10000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 80 kDa |
MST1 has an 80.3 kDa predicted core but is glycosylated and disulfide-linked into an alpha/beta heterodimer, matching the empirically observed ~80 kDa band.
| single band at approximately 80 kDa | matches the glycosylated single-chain pro-MST1 precursor, the dominant form detected in cells and serum |
| band running slightly above the 80.3 kDa predicted mass, sometimes smeared | N-linked glycosylation at Asn72, Asn296, and Asn615 adds carbohydrate mass and microheterogeneity |
| band near 80 kDa retained intact under non-reducing conditions | the proteolytically generated alpha and beta chains stay joined by an inter-chain disulfide bond, co-migrating as one complex |
| loss of the ~80 kDa band and appearance of smaller chains after strong reduction | reducing agents break the inter-chain disulfide, separating the disulfide-linked alpha/beta heterodimer into its two component chains |
| little or no band in whole-cell lysate | MST1 is a secreted protein, so most of the mature protein leaves the cell rather than accumulating intracellularly |
| Predicted mass (80.3 kDa, UniProt) | sets the baseline single-chain polypeptide size before any modification |
| N-glycosylation at Asn72, Asn296, and Asn615 | adds carbohydrate mass and heterogeneity, nudging the band above the 80.3 kDa core and broadening it |
| Inter-chain disulfide linking the alpha and beta chains | holds the proteolytically processed chains together near 80 kDa under non-reducing conditions; full reduction resolves them into separate smaller alpha and beta chains |
| Signal peptide (residues 1-18) | is cleaved during secretion, so the mature secreted protein runs slightly smaller than the unprocessed translated precursor |
| Secreted subcellular location | shifts most mature protein into conditioned media or serum, lowering the signal detected in whole-cell lysate |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | MST1 is secreted, so little full-length or processed protein remains intracellular | probe concentrated conditioned media or serum/plasma instead of, or in addition to, whole-cell lysate |
| Band higher than expected | N-glycosylation at three sites (Asn72, Asn296, Asn615) adds mass above the 80.3 kDa predicted core | treat lysate with PNGase F and confirm the band shifts down toward the predicted mass |
| Band lower than expected | cleavage of the signal peptide during secretion yields a mature protein smaller than the full translated precursor | compare against a construct or standard known to retain versus lack the signal peptide before concluding degradation |
| Broad smear instead of sharp band | heterogeneous occupancy and processing of the three N-glycosylation sites broadens the apparent mass | run a lower-percentage or longer gel, or deglycosylate with PNGase F for a tighter band |
| Multiple bands | partial versus complete reduction of the inter-chain disulfide linking the alpha and beta chains yields both the intact ~80 kDa complex and separated chains | standardize on either fully reducing or fully non-reducing sample buffer across lanes for consistent comparison |
| Fragments below expected size | proteolytic processing of the alpha/beta chains during endogenous maturation or sample handling can generate smaller species | add protease inhibitors during lysis, keep samples cold, and avoid repeated freeze-thaw |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MST1, answered from its protein features.
BosterBio's MST1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Boster's anti-MST1 antibodies are top-performing, widely cited reagents rigorously validated for western blot specificity, cross-confirmed against negative-tissue controls and orthogonal detection methods to ensure confident, reproducible MST1 detection.
Which to pick: Only one Boster anti-MST1 antibody is listed, A01069-1, which includes an actual western blot validation image—making it the clear, straightforward choice for your MST1 WB experiments.